SANGAMO BIOSCIENCES, INC.

Patent Owner

Follow Compare Add to Portfolio 2Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 12457
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 46210
 
 
 
C07K PEPTIDES 4486
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3293
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2873
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1977
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 689
 
 
 
A01H NEW PLANTS OR PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES 5122
 
 
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS540
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5188

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0218,349 COMPOSITIONS FOR LINKING DNA-BINDING DOMAINS AND CLEAVAGE DOMAINSDec 15, 16Aug 03, 17[C12N]
2017/0211,075 TARGETED DISRUPTION OF THE T CELL RECEPTORDec 15, 16Jul 27, 17[C12N]
2017/0196,992 METHODS AND COMPOSITIONS FOR ENGINEERING IMMUNITYNov 21, 16Jul 13, 17[C12N, A61K, C07K]
2017/0173,080 TARGETED DISRUPTION OF THE MHC CELL RECEPTORDec 15, 16Jun 22, 17[C12N, A61K, C07K]
2017/0096,460 HTT REPRESSORS AND USES THEREOFSep 23, 16Apr 06, 17[C07K]
2017/0016,027 DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERINGJul 13, 16Jan 19, 17[C12N, A61K]
2016/0369,262 NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSIONJun 03, 16Dec 22, 16[C12N, A61K]
2016/0326,548 METHODS AND COMPOSITIONS FOR INCREASING TRANSGENE ACTIVITYApr 28, 16Nov 10, 16[C12N]
2016/0168,593 METHODS AND COMPOSITIONS FOR ENHANCING TARGETED TRANSGENE INTEGRATIONDec 14, 15Jun 16, 16[C12N]
2016/0060,656 METHODS AND COMPOSITIONS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASESOct 01, 15Mar 03, 16[C12N, A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9650648 Methods and compositions for treatment of a genetic conditionAug 29, 13May 16, 17[C12N, C07H, C12Q, C07K]
9629930 Methods and compositions for treating hemophilia BOct 08, 15Apr 25, 17[A61N, C12N, A01N, C12P, A61K]
9631186 Methods and compositions for targeted single-stranded cleavage and targeted integrationOct 28, 15Apr 25, 17[C12N, C07H, C12P, A61K, C07K]
9631187 Methods and compositions for gene correctionOct 29, 15Apr 25, 17[C12N, A61K, C07K]
9631201 Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesisNov 25, 13Apr 25, 17[C12N, C07K]
9624498 Methods and compositions for regulation of zinc finger protein expressionMar 18, 15Apr 18, 17[C12N]
9624509 Modulation of stem cells using zinc finger proteinsMay 05, 14Apr 18, 17[C12N, C07H, A61K, G01N]
9597357 T cell modifying compounds and uses thereofOct 10, 13Mar 21, 17[A61K, C07K]
9574211 Methods and compositions for prevention or treatment of a diseaseMay 13, 15Feb 21, 17[C12N, C07H, A61K, C07K]
9566352 Methods and compositions for inhibiting viral entry into cellsSep 26, 11Feb 14, 17[C12N, A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0037,304 METHODS AND COMPOSITIONS FOR MODIFICATION OF HLAABANMar 12, 14Feb 05, 15[C12N, A61K]
2014/0325,691 REGULATION OF ENDOGENOUS GENE EXPRESSION IN CELLS USING ZINC FINGER PROTEINSABANJun 05, 14Oct 30, 14[A01K, C12Q, G01N]
2014/0205,576 METHODS AND COMPOSITIONS FOR INCREASED TRANSGENE EXPRESSIONABANMar 24, 14Jul 24, 14[C12N]
2013/0216,579 METHODS AND COMPOSTITIONS FOR GENE EDITING OF A PATHOGENABANJan 23, 13Aug 22, 13[C12N, C07K]
2013/0198,878 ORGANISMS HOMOZYGOUS FOR TARGETED MODIFICATIONABANMar 14, 13Aug 01, 13[C12N, A01K]
2013/0171,732 METHODS AND COMPOSITIONS FOR REGULATING HIV INFECTIONABANOct 04, 12Jul 04, 13[C12N]
2013/0164,785 METHODS AND COMPOSITIONS FOR INACTIVATING GLUTAMINE SYNTHETASE GENE EXPRESSIONABANSep 06, 12Jun 27, 13[C07K]
2012/0252,122 METHODS AND COMPOSITIONS FOR INCREASING PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS (IPSCS)ABANDec 15, 11Oct 04, 12[C12N]
2012/0214,241 ZINC FINGER NUCLEASE MODIFICATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2) MUTANT FIBROBLASTS AND IPSCSABANDec 15, 11Aug 23, 12[C12N]
2012/0204,282 METHODS AND COMPOSITIONS FOR TREATING OCCULAR DISORDERSABANFeb 06, 12Aug 09, 12[C12N, C07H, A01K, A61P, A61K, C07K]
2012/0196,370 METHODS AND COMPOSITIONS FOR TARGETED GENOMIC DELETIONABANDec 02, 11Aug 02, 12[C12N]
2012/0088,677 METHODS AND COMPOSITIONS FOR ANALYSIS OF REGULATORY SEQUENCESABANDec 19, 11Apr 12, 12[C40B]
2011/0306,559 METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAINABANDec 23, 09Dec 15, 11[C12N, C07H, A61P, A61K, C07K]
8071564 Regulation of angiogenesis with zinc finger proteinsExpiredSep 03, 09Dec 06, 11[C07H, A61K]
2011/0281,937 Methods and compositions for treating neuropathic and neurodegenerative conditionsABANJan 03, 11Nov 17, 11[A61P, A61K]
2011/0244,474 Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsABANApr 28, 11Oct 06, 11[C12N, C07H, C12Q]
2011/0247,089 Organisms homozygous for targeted modificationABANApr 20, 11Oct 06, 11[C12N, A01K, A01H]
7923542 Libraries of regulatory sequences, methods of making and using sameExpiredOct 24, 01Apr 12, 11[C07H, C12Q, G01N]
2011/0014,616 Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsABANJun 29, 10Jan 20, 11[C12N, C07H, C12Q]
2010/0311,124 Methods and compositions for inactivating glutamine synthetase gene expressionABANJul 09, 10Dec 09, 10[C12N, C12P]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.